Skip to main content
SpringerLink
Log in
Book cover

Phlebology, Vein Surgery and Ultrasonography pp 281–292Cite as

Deep Vein Thrombosis

  • Chapter
  • First Online:

  • 1558 Accesses

Abstract

Venous thromboembolism (VTE) is characterized by the acute pathology of deep venous thrombosis (DVT) and/or pulmonary embolus (PE). DVT affects nearly a quarter million people per year in the USA, with an incidence of about one case per 1000 people. In addition to its local effects with inflammation, swelling, and pain, DVT is responsible for the vast majority of pulmonary embolism (PE). This chapter discusses the incidence, pathophysiology, diagnosis, and management of DVT.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ludwig Christian Stern. Ebers G. ed (in German). PapyrosEbers: Das hermetischeBuchüber die Arzeneimittel der altenÄgypter in hieratischerSchrift, herausgegebenmitInhaltsangabe und Einleitungversehen von Georg Ebers, mitHieroglyphisch-LateinischemGlossar von Ludwig Stern, mitUnterstützung des KöniglichSächsischenCultusministerium. 2 (1st ed.). Leipzig: W. Englemann; 1875.

    Google Scholar 

  2. ANNING ST. The historical aspects of venous thrombosis. Med Hist. 1957;1(1):28–37.

    Article  PubMed  CAS  Google Scholar 

  3. Kempf EJ. From Hippocrates to Galen. Med Libr Hist J. 1904;2(4):282–307.

    CAS  Google Scholar 

  4. Dexter L, Folch-Pi W. Venous thrombosis. An account of the first documented case. JAMA. 1974;228(2):195–6.

    Article  PubMed  CAS  Google Scholar 

  5. Hunter J. Observations on the inflammation of the internal coasts of veins. Trans Soc Improv Med Chir Knowl. 1793;1:18–25.

    Google Scholar 

  6. Virchow RLK. Ueber die akuteEntzuendung der Arterien. Archiv fur pathologische Anatomie und Physiologie und fur klinischeMedizin Berlin. 1847;1:272–4.

    Google Scholar 

  7. Dickson BC. Venous thrombosis: on the history of Virchow’s triad. Univ Toronto Med J. 2004;81:166–71.

    Google Scholar 

  8. Murray G. Anticoagulant therapy with heparin. Am J Med. 1947;3(4):468–71.

    Article  PubMed  CAS  Google Scholar 

  9. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA. 1995;274(4):335–7.

    Article  PubMed  CAS  Google Scholar 

  10. http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf

  11. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA. 1998;279(6):458–62.

    Article  PubMed  CAS  Google Scholar 

  12. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT study. Arch Intern Med. 1991;151:933–8.

    Article  PubMed  Google Scholar 

  13. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:257–70.

    Google Scholar 

  14. Alpert JS, Smith R, Carlson J, Ockene IS, Dexter L, Dalen JE. Mortality in patients treated for pulmonary embolism. JAMA. 1976;236:1477–80.

    Article  PubMed  CAS  Google Scholar 

  15. Salzman EW, Hirsh J. The epidemiology, pathogenesis, and natural history of venous thrombosis. In: Colman RW, Hirsh J, Salzman EW, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott & Co; 1994. p. 1275–96.

    Google Scholar 

  16. Prandoni P, Lensing AWA, Cogo A, et al. The long-term clinical course of acute deep vein thrombosis. Ann Intern Med. 1996;125:1–7.

    Article  PubMed  CAS  Google Scholar 

  17. Ruggeri M, Tosetto A, Castaman G, Rodeghiero F. Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep-vein thrombosis. Lancet. 2001;357(9254):441.

    Article  PubMed  CAS  Google Scholar 

  18. Hamoud S, Nitecky S, Engel A, Goldsher D, Hayek T. Hypoplasia of the inferior vena cava with azygous continuation presenting as recurrent leg deep vein thrombosis. Am J Med Sci. 2000;319(6):414–6.

    Article  PubMed  CAS  Google Scholar 

  19. Greenfield LJ, Proctor MC. The percutaneous greenfield filter: outcomes and practice patterns. J Vasc Surg. 2000;32(5):888–93.

    Article  PubMed  CAS  Google Scholar 

  20. Tsuji Y, Goto A, Hara I, Ataka K, Yamashita C, Okita Y, et al. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. J Vasc Surg. 2001;33(4):789–96.

    Article  PubMed  CAS  Google Scholar 

  21. Stamatakis JD, Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. Br Med J. 1977;2(6081):223–5. [Full Text].

    Article  PubMed  CAS  Google Scholar 

  22. Alikhan R, Cohen AT, Combe S, Samama MM, Desjardins L, Eldor A, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Arch Intern Med. 2004;164(9):963–8.

    Article  PubMed  Google Scholar 

  23. Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;132(11):853–61.

    Article  PubMed  CAS  Google Scholar 

  24. Nordström M, Lindblad B, Bergqvist D, Kjellström T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232(2):155–60.

    Article  PubMed  Google Scholar 

  25. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85(3):607–14.

    PubMed  Google Scholar 

  26. Anderson Jr FA, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med. 1992;152(8):1660–4.

    Article  PubMed  Google Scholar 

  27. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after strokes. Part I–incidence and predisposing factors. Br Med J. 1976;1(6019):1178–81. [Full Text].

    Article  PubMed  CAS  Google Scholar 

  28. Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, et al. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer. 1991;67(2):541–5.

    Article  PubMed  CAS  Google Scholar 

  29. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 1992;11(3–4):237–48.

    Article  PubMed  CAS  Google Scholar 

  30. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk W, et al. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med. 1988;318(7):404–7.

    Article  PubMed  CAS  Google Scholar 

  31. Schroeder R. Massive thromboembolism captured by real-time echocardiography. J Surg Radiol. 2010;1:1(1).

    Google Scholar 

  32. Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988;208(2):227–40. [Full Text].

    Article  PubMed  CAS  Google Scholar 

  33. Clagett GP, Anderson Jr FA, Heit J, Levine MN, Wheeler HB. Prevention of venous thromboembolism. Chest. 1995;108(4 Suppl):312S–34.

    Article  PubMed  CAS  Google Scholar 

  34. Beaty JH, editor. Orthopaedic knowledge. Rosemont: AAOS; 1999. p. 63–72.

    Google Scholar 

  35. Rialon KL, Ceppa EP, Mureebe L. Case study: a 53-year-old female with lower abdominal pain. J Surg Radiol. 2011;1:2(3).

    Google Scholar 

  36. Kakkar VV, Howe CT, Nicolaides AN, Renney JT, Clarke MB. Deep vein thrombosis of the leg. Is there a “high risk” group? Am J Surg. 1970;120(4):527–30.

    Article  PubMed  CAS  Google Scholar 

  37. Motykie GD, Caprini JA, Arcelus JI, Zebala LP, Lee CE, Finke NM, et al. Risk factor assessment in the management of patients with suspected deep venous thrombosis. Int Angiol. 2000;19(1):47–51.

    PubMed  CAS  Google Scholar 

  38. Motykie GD, Zebala LP, Caprini JA, Lee CE, Arcelus JI, Reyna JJ, et al. A guide to venous thromboembolism risk factor assessment. J Thromb Thrombolysis. 2000;9(3):253–62.

    Article  PubMed  CAS  Google Scholar 

  39. Schafer AI. Hypercoagulable states: molecular genetics to clinical practice. Lancet. 1994;344(8939–8940):1739–42.

    Article  PubMed  CAS  Google Scholar 

  40. Meissner MH, Strandness E. Pathophysiology and natural history of acute deep venous thrombosis. In: Rutherford’s vascular surgery. 2005. p. 2124–42.

    Google Scholar 

  41. Ho CH, Chau WK, Hsu HC, Gau JP, Yu TJ. Causes of venous thrombosis in fifty Chinese patients. Am J Hematol. 2000;63(2):74–8.

    Article  PubMed  CAS  Google Scholar 

  42. Vandenbrouke JP, Bloemenkamp KW, Rosendaal FR, Helmerhorst FM. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives. BMJ. 2000;320(7226):57–8.

    Article  PubMed  CAS  Google Scholar 

  43. Neff MJ, ACEP. ACEP releases clinical policy on evaluation and management of pulmonary embolism. Am Fam Physician. 2003;68(4):759–60.

    PubMed  Google Scholar 

  44. Wells P, Anderson D, Rodger M, Ginsberg J, Kearon C, Gent M, Turpie A, Bormanis J, Weitz J, Chamberlain M, Bowie D, Barnes D, Hirsh J. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000;83(3):416–20.

    PubMed  CAS  Google Scholar 

  45. Woller SC, Stevens SM, Jones JP, Lloyd JF, Evans RS, Aston VT, Elliott CG. Derivation and validation of a simple model to identify venous thromboembolism risk in medical patients. Am J Med. 2011;124(10):947–954.e2.

    Article  PubMed  Google Scholar 

  46. Khorana AA. Risk assessment and prophylaxis for VTE in cancer patients. J Natl Compr Canc Netw. 2011;9(7):789–97.

    PubMed  CAS  Google Scholar 

  47. Pannucci CJ, Bailey SH, Dreszer G, Fisher Wachtman C, Zumsteg JW, Jaber RM, Hamill JB, Hume KM, Rubin JP, Neligan PC, Kalliainen LK, Hoxworth RE, Pusic AL, Wilkins EG. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212(1):105–12. Epub 2010 Nov 18.

    Article  PubMed  Google Scholar 

  48. Barbar S, Noventa F, Rossetto V, Ferrari A, Brandolin B, Perlati M, De Bon E, Tormene D, Pagnan A, Prandoni P. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450–7.

    Article  PubMed  CAS  Google Scholar 

  49. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model. Circulation. 2010;121(14):1630–6.

    Article  PubMed  Google Scholar 

  50. Mitchell L, Lambers M, Flege S, Kenet G, Li-Thiao-Te V, Holzhauer S, Bidlingmaier C, Frühwald MC, Heller C, Schmidt W, Pautard B, Nowak-Göttl U. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood. 2010;115(24):4999–5004.

    Article  PubMed  CAS  Google Scholar 

  51. Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227–35.

    Article  PubMed  CAS  Google Scholar 

  52. Desai SS, Shortell CK, editors. Clinical review of vascular surgery. 1st ed. New York: Catalyst Publishers; 2010.

    Google Scholar 

  53. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(8):1687–93.

    Article  PubMed  CAS  Google Scholar 

  54. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087–97.

    PubMed  CAS  Google Scholar 

  55. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;57:765–81.

    Article  CAS  Google Scholar 

  56. Flössel C, Luther T, Müller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry. 1994;101:449–53.

    Article  PubMed  Google Scholar 

  57. Bouchard BA, Shatos MA, Tracy PB. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation. Arterioscler Thromb Vasc Biol. 1997;17:1–9.

    Article  PubMed  CAS  Google Scholar 

  58. Schecter AD, Spirn B, Rossikhina M, Giesen PL, Bogdanov V, Fallon JT, Fisher EA, Schnapp LM, Nemerson Y, Taubman MB. Release of active tissue factor by human arterial smooth muscle cells. Circ Res. 2000;87:126–32.

    Article  PubMed  CAS  Google Scholar 

  59. Mackman N, Sawdey MS, Keeton MR, Loskutoff DJ. Murine tissue factor gene expression in vivo: tissue and cell specificity and regulation by lipopolysaccharide. Am J Pathol. 1993;143:76–84.

    PubMed  CAS  Google Scholar 

  60. Erlich JH, Parry GCN, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U S A. 1999;96:8138–43.

    Article  PubMed  CAS  Google Scholar 

  61. Hartzell S, Ryder K, Lanahan A, Lau LF, Nathans D. A growth factor-responsive gene of murine BALB/c 3T3 cells encodes a protein homologous to human tissue factor. Mol Cell Biol. 1989;9:2567–73.

    PubMed  CAS  Google Scholar 

  62. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood. 1996;88:1583–7.

    PubMed  CAS  Google Scholar 

  63. Taylor Jr FB, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127–34.

    PubMed  Google Scholar 

  64. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol. 1989;9:2752–5.

    PubMed  CAS  Google Scholar 

  65. Ritis K, Doumas M, Mastellos D, Micheli A, Giaglis S, Magotti P, Rafail S, Kartalis G, Sideras P, Lambris JD. A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways. J Immunol. 2006;177:4794–802.

    PubMed  CAS  Google Scholar 

  66. Hemker HC, Siepel T, Altman R, Loeliger EA. Kinetic aspects of the interaction of blood-clotting enzymes. II. The relation between clotting time and plasma concentration in prothrombin-time estimations. Thromb Diath Haemorrh. 1967;17(3–4):349–57.

    PubMed  CAS  Google Scholar 

  67. Salomon O, Steinberg D, Dardik R, Rosenberg N, Zivelin A, Tamarin I, Ravid B, Berliner S, Seligsohn U. Inherited factor XI deficiency confers no protection against acute myocardial infarction. J Thromb Haemost. 2003;1:658–61.

    Article  PubMed  CAS  Google Scholar 

  68. Doggen CJ, Rosendaal FR, Meijers JC. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood. 2006;108:4045–51.

    Article  PubMed  CAS  Google Scholar 

  69. Gailani D, Renné T. The intrinsic pathway of coagulation: a target for treating thromboembolic disease? J Thromb Haemost. 2007;5:1106–12.

    Article  PubMed  CAS  Google Scholar 

  70. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991;266:7353–8.

    PubMed  CAS  Google Scholar 

  71. McGehee WG, Klotz TA, Epstein DJ, Rapaport SI. Coumarin necrosis associated with hereditary protein C deficiency. Ann Intern Med. 1984;101(1):59–60.

    Article  PubMed  CAS  Google Scholar 

  72. Gallop PM, Lian JB, Hauschka PV. Carboxylated calcium-binding proteins and vitamin K. N Engl J Med. 1980;302(26):1460–6.

    Article  PubMed  CAS  Google Scholar 

  73. Atoda H, Morita T. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurusflavoviridis (Habu snake): isolation and characterization. J Biochem. 1989;106(5):808–13.

    PubMed  CAS  Google Scholar 

  74. Santacroce R, Sarno M, Cappucci F, Sessa F, Colaizzo D, Brancaccio V, Grandone E, Margaglione M. Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost. 2006;4(11):2417–22.

    Article  PubMed  CAS  Google Scholar 

  75. Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper Jr KV, Popovich Jr J, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK, PIOPED II Investigators. Multidectectorcomputed tomography for acute pulmonary embolism. N Engl J Med. 2006;354(22):2317–27.

    Article  PubMed  CAS  Google Scholar 

  76. Kearon C, Kahn S, Agnelli G. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454S–545.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Duke University Medical Center, Durham, NC, USA

    Sapan S. Desai MD, PhD, MBA

  2. Department of Cardiothoracic and Vascular Surgery, University of Texas at Houston Medical School, Houston, TX, USA

    Sapan S. Desai MD, PhD, MBA & Ali Azizzadeh MD

  3. 757 Pacific Street, Suite C-2, Monterey, CA, 93940, USA

    Eric Mowatt-Larssen MD, FACPh, RPhS

Authors
  1. Sapan S. Desai MD, PhD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric Mowatt-Larssen MD, FACPh, RPhS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ali Azizzadeh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sapan S. Desai MD, PhD, MBA .

Editor information

Editors and Affiliations

  1. Vein Specialists of Monterey, Monterey, California, USA

    Eric Mowatt-Larssen

  2. Department of Surgery, University of Texas-Houston Duke University School of Medicine, Houston, Texas, USA

    Sapan S. Desai

  3. MSB 5.030, University of Texas-Houston, Houston, Texas, USA

    Anahita Dua

  4. Vascular Surgery, Duke University Medical Center, Durham, North Carolina, USA

    Cynthia E. K. Shortell

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Desai, S.S., Mowatt-Larssen, E., Azizzadeh, A. (2014). Deep Vein Thrombosis. In: Mowatt-Larssen, E., Desai, S., Dua, A., Shortell, C. (eds) Phlebology, Vein Surgery and Ultrasonography. Springer, Cham. https://doi.org/10.1007/978-3-319-01812-6_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-01812-6_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-01811-9

  • Online ISBN: 978-3-319-01812-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation